Clinical Management of Patients With Parenteral Nutrition-Dependent Short Bowel Syndrome During Teduglutide Therapy.

about

Teduglutide: A Review in Short Bowel Syndrome.

P2860

Q39134556-6766841B-6CC0-46CD-AA43-76D24A2B5F27

P2860

Clinical Management of Patients With Parenteral Nutrition-Dependent Short Bowel Syndrome During Teduglutide Therapy.

Item

http://www.wikidata.org/entity/Q53454261

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Clinical Management of Patient ...... me During Teduglutide Therapy.

@en

Clinical Management of Patient ...... me During Teduglutide Therapy.

@nl

type

Item

label

Clinical Management of Patient ...... me During Teduglutide Therapy.

@en

Clinical Management of Patient ...... me During Teduglutide Therapy.

@nl

prefLabel

Clinical Management of Patient ...... me During Teduglutide Therapy.

@en

Clinical Management of Patient ...... me During Teduglutide Therapy.

@nl

P1476

Clinical Management of Patient ...... me During Teduglutide Therapy.

@en

P2093

Bruce P Kinosian

http://www.w3.org/2001/XMLSchema#string

Charlene Compher

http://www.w3.org/2001/XMLSchema#string

Joseph I Boullata

http://www.w3.org/2001/XMLSchema#string

Nancy Stoner

http://www.w3.org/2001/XMLSchema#string

Octavia Pickett-Blakely

http://www.w3.org/2001/XMLSchema#string

Phyllis Schiavone

http://www.w3.org/2001/XMLSchema#string

P2860

Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome

Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.

Short bowel syndrome and intestinal failure: consensus definitions and overview.

Outcome on home parenteral nutrition for benign intestinal failure: a review of the literature and benchmarking with the European prospective survey of ESPEN.

New approaches to the treatments of short bowel syndrome-associated intestinal failure.

Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure.

ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults.

Maintenance of parenteral nutrition volume reduction, without weight loss, after stopping teduglutide in a subset of patients with short bowel syndrome.

P304

1183-1190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0148607115594010

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26111832

http://www.w3.org/2001/XMLSchema#string

Clinical Management of Patients With Parenteral Nutrition-Dependent Short Bowel Syndrome During Teduglutide Therapy.

about

P2860

P2860

Clinical Management of Patients With Parenteral Nutrition-Dependent Short Bowel Syndrome During Teduglutide Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698